Merck, US FDA restrict high-dose Zocor after muscle damage reports
This article was originally published in Scrip
Executive Summary
The use of Merck's 80mg dose of its cholesterol-lowering medicine Zorcor (simvastatin) – the highest dose available – should be limited to patients who have been taking that amount chronically, or for 12 months or more, because of an increased risk of muscle damage, the company and US regulators said on 8 June.